Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market ...

Dylan Lewis: We're talking three stocks down bad. Motley Fool Money starts down. I'm Dylan Lewis, I'm joined over the ...

How can you tell them apart? Here’s a handy video fact sheet with some answers. Heat suspend Jimmy Butler; will listen to trade offers How To Fill Raised Gardening Beds for a Successful Harvest ...

Meta announced this week it was ending third-party fact-checking and moving towards community notes. Some experts fear it ...

A retired infection control nurse says she has never known a situation in hospitals where four viruses are rife at such high levels ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

The NHS guidance is clear. The delivery of care in “temporary escalation spaces” is “not acceptable and should not be considered as standard”. But the reality for health staff across England is that ...

Four winter bugs are circulating in the UK in what has been dubbed the “quad-demic” with escalating cases of flu, Covid, norovirus and the cold-like respiratory syncytial virus (RSV ...

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

COVID-19 and flu activity is increasing in most parts of the country and RSV activity remains very high, especially in young children. Respiratory illness activity in Florida is very high ...

The report also showed emergency department visits for RSV — a common virus that typically causes mild, cold-like symptoms — are at "very high" levels in the state. ER visits for COVID-19 are ...